Table 3 Univariable analyses for prediction of fatigue in ICU-admitted individuals at one year after COVID-19.
Predictor | Univariable analysis | |
|---|---|---|
Odds ratio (95% CI) | P-value | |
Dependent variable: A total score ≥ 22 of the Swedish Fatigue Assessment Scale (n = 104*) | ||
Age | 0.96 (0.92–0.99) | 0.042 |
Female sex (male sex = ref.) | 1.54 (0.58–4.21) | 0.37 |
Length of stay in ICU | 1.04 (1.00–1.07) | 0.032 |
Hypertension | 1.12 (0.50–2.53) | 0.79 |
Diabetes mellitus | 1.76 (0.63–4.94) | 0.29 |
Coronary heart disease | 1.06 (0.42–2.68) | 0.91 |
Asthma | 4.20 (0.50–35.54) | 0.19 |
Sepsis | 0.93 (0.42–2.08) | 0.85 |
Embolic event | 2.90 (0.33–25.84) | 0.34 |
ARDS | 0.90 (0.75–1.08) | 0.26 |
Dependent variable: A physical fatigue score of ≥ 11 of the Swedish Fatigue Assessment Scale (n = 105) | ||
Age | 0.99 (0.95–1.02) | 0.42 |
Female sex (male sex = ref.) | 1.34 (0.50–3.60) | 0.57 |
Length of stay in ICU | 1.06 (1.02–1.11) | 0.006 |
Hypertension | 1.87 (0.79–4.40) | 0.15 |
Diabetes mellitus | 1.50 (0.53–4.22) | 0.45 |
Coronary heart disease | 2.00 (0.72–5.54) | 0.18 |
Asthma | 3.31 (0.36–26.78) | 0.31 |
Sepsis | 0.59 (0.25–1.35) | 0.21 |
ARDS | 0.85 (0.71–1.03) | 0.10 |
Embolic event | 2.54 (0.29–22.63) | 0.41 |
Dependent variable: A mental fatigue score of ≥ 11 of the Swedish Fatigue Assessment Scale (n = 104*) | ||
Age | 0.96 (0.92–0.99) | 0.02 |
Female sex (male sex = ref.) | 1.92 (0.74–4.96) | 0.18 |
Length of stay in ICU | 0.98 (0.96–1.00) | 0.10 |
Hypertension | 0.75 (0.34–1.65) | 0.48 |
Diabetes mellitus | 2.07 (0.77–5.57) | 0.15 |
Coronary heart disease | 1.33 (0.54–3.31) | 0.54 |
Asthma | 1.32 (0.30–5.85) | 0.71 |
Sepsis | 1.18 (0.54–2.57) | 0.69 |
ARDS | 0.92 (0.77–1.10) | 0.36 |
Embolic event | 1.59 (0.28–9.11) | 0.60 |
